Publications by authors named "Helene Vincent"

Claim this Profile
P
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.
Monica Pierro, Capucine Baldini, Edouard Auclin, Hélène Vincent, Andreea Varga

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on cancer care in older patients in France.
Mathilde Hauchecorne, Monica Pierro, Etienne Brain, Michael Bringuier, Pierre Soubeyran, Hélène Vincent

Ecancermedicalscience· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies.
Capucine Baldini, Patricia Martin Romano, Anne-Laure Voisin, François-Xavier Danlos, Stéphane Champiat, Hélène Vincent, Vincent Ribrag

Eur J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemophagocytic histiocyte in a peripheral blood film.
Ivan Sloma, Hélène Vincent, Amal Addebbous, Claire Rivoisy, Ali G Turhan

Br J Haematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.
Marie Laurent, Elena Paillaud, Christophe Tournigand, Philippe Caillet, Aurélie Le Thuaut, Hélène Vincent

Oncologist· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study.
Evelyne Liuu, Florence Canouï-Poitrine, Christophe Tournigand, Marie Laurent, Philippe Caillet, Helene Vincent

J Geriatr Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
François Piette, Joël Belmin, Hélène Vincent, Nicolas Schmidt, Sylvie Pariel

Alzheimers Res Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis